Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-26

FDA Approved: LACOSAMIDE ORAL SOLUTION — Original Application (Ajenat Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved lacosamide oral solution under an original generic application (ANDA 219699) from Ajenat Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide oral solution (lacosamide)

Snippet

ORIG AP for LACOSAMIDE ORAL SOLUTION (LACOSAMIDE)